Le Lézard
Classified in: Science and technology, Business, Covid-19 virus
Subjects: ASI, CXP, DEI

Genpact to Expand Presence in Fukuoka, Japan


FUKUOKA, Japan, Aug. 18, 2021 /PRNewswire/ -- Genpact Japan K.K. (Chiyoda-ku, Tokyo), the Japanese subsidiary of Genpact (NYSE: G), a global professional services firm focused on delivering digital transformation, today announced that it will open a new delivery center in Fukuoka as the company continues to expand in Japan.

Genpact will help a global leader in the high-tech industry transform its customer service operations at the site, expect to expand to provide innovative digital and analytics capabilities for optimizing operations and creating compelling experiences to clients in targeted industries including high-tech, manufacturing, services, consumer goods, and finance. The center will leverage Genpact's deep technology and process expertise from transforming and managing operations for hundreds of global companies via its network of delivery centers around the world, including four existing sites in Japan.

"Our new delivery center in Fukuoka will take advantage of the strong talent base in the city and provide additional flexible sourcing options and high-quality services for our clients," said Junichi Tanaka, Japan chief executive officer, Genpact. "We're excited to continue our growth in the Kyushu region for both Genpact and our clients and look forward to being an active partner in the business community."

The Fukuoka site will operate as a hybrid environment with 120 employees working from home and the office in Hakata-ku in Fukuoka city, using learnings from similar operations as Genpact and its clients have adapted to new ways of working during the COVID-19 pandemic.

"Fukuoka is a vibrant prefecture in western Japan with one of the largest populations and economies in the region, an ideal business environment, and a large talent pool," said Hiroto Hirase, director, investment promotion division, department of commerce and industry, Fukuoka Prefectural Government. "We continue to attract global companies such as Genpact, who are actively promoting the development of digital technologies that expand opportunities for both people and companies."

About Genpact
Genpact (NYSE: G) is a global professional services firm that makes business transformation real. Led by our purpose -- the relentless pursuit of a world that works better for people -- we drive digital-led innovation and digitally enabled intelligent operations for our clients. Guided by our experience reinventing and running thousands of processes for hundreds of clients, many of them Global Fortune 500 companies, we drive real-world transformation at scale. We think with design, dream in digital, and solve problems with data and analytics. Combining our expertise in end-to-end operations and our AI-based platform, Genpact Cora, we focus on the details ? all 90,000+ of us. From New York to New Delhi, and more than 30 countries in between, we connect every dot, reimagine every process, and reinvent the ways companies work. We know that reimagining each step from start to finish creates better business outcomes. Whatever it is, we'll be there with you ? accelerating digital transformation to create bold, lasting results ? because transformation happens here. Get to know us at Genpact.com and on LinkedInTwitterYouTube, and Facebook.

MEDIA CONTACTS:

 

Satoko Hashiba
Genpact Media Relations - Japan
[email protected]
+81-80-4944-3907

 

Ashton Consulting

[email protected] 

 

SOURCE Genpact


These press releases may also interest you

19 mai 2024
ICIS, a global source of commodity intelligence, has announced the 16th Asian Base Oils and Lubricants Conference will take place in Singapore, 27-28 June 2024. The event offers a platform for senior executives to connect with peers, potential...

19 mai 2024
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...

19 mai 2024
Amgen and AstraZeneca today announced the results of the Phase 2a COURSE trial evaluating Tezspire® (tezepelumab-ekko) in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of baseline blood...

18 mai 2024
Emmy-winning actor and St. Louis native Jon Hamm took the stage Saturday, May 18, to offer words of wisdom to the newest graduates of Saint Louis University (SLU) during the University's spring commencement in St. Louis. ...

18 mai 2024
Nearly 900 undergraduates of the Class of 2024 celebrated their send-off from Bentley University in a very different way than their 2020 arrival amid the COVID-19 pandemic. The 105th undergraduate commencement ceremony was marked by maskless smiles,...

18 mai 2024
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...



News published on and distributed by: